Publication date: Mar 01, 2025
Rifampin-resistant Mycobacterium tuberculosis was identified by the World Health Organization as a pathogen of public health critical importance. During 2014-2023, an increase in fluoroquinolone resistance in rifampin-resistant M. tuberculosis from Kharkiv, Ukraine, was observed. Efforts to mitigate factors contributing to resistance should be prioritized to prevent further escalation of that threat.
Semantics
| Type | Source | Name |
|---|---|---|
| disease | MESH | Drug-Resistant Tuberculosis |
| drug | DRUGBANK | Rifampicin |
| disease | IDO | pathogen |
| disease | MESH | tuberculosis |
| pathway | KEGG | Tuberculosis |
| disease | IDO | bacteria |
| disease | IDO | history |
| disease | MESH | respiratory infections |